Article

Palonosetron Hydrochloride Available in Prefilled Syringe

In related news, manufacturer of palonosetron hydrochloride was recently awarded the Drug Shortage Assistance Award from the US FDA,

Palonosetron hydrochloride (Simplist, Fresenius Kabi) is now available in a prefilled injection formulation, according to a recently released media statement. The injection is available in a .25 mg per 5 mL single dose strength.

Palonosetron hydrochloride Injection is a serotonin-3 (5-HT3) receptor antagonist indicated in adults for: moderately emetogenic cancer chemotherapy to prevent acute and delayed nausea and vomiting and highly emetogenic cancer chemotherapy to prevent acute nausea and vomiting associated with initial and repeat courses. It is also indicated to prevent acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy in some pediatric patients.

Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The company was recently awarded the Drug Shortage Assistance Award from the US FDA, which recognized the company’s role in helping to mitigate a shortage of IV saline after Hurricane Maria in 2017.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com